About: Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $19.20 (-3.03%)
VOR NASDAQ Vor Biopharma Inc
Vor Biopharma Inc share price
VOR price activity
Last Price
$19.100
Change (24hr)
-0.70 USD (-3.54%)
Volume
485.92K
Volume (4w avg)
-
Open
$19.50
Day Range
$19.09 - $19.50
Previous Close
$19.80
Last Trade
13 Oct, 5:35 pm GMT+0
Delayed
13 Oct, 5:35 pm GMT+0
VOR price performance
Delayed
13 Oct, 5:35 pm GMT+0
VOR Market Signals